Table 1.

Subject characteristics

Subject	Age	Gender	FEV1 (% predicted)	COPD severity	Lobectomy site	Current tobacco use	Years since last tobacco use	Total pack-years	ICSa use	LABAb use
1	82	Male	1.28 (64.7)	Moderate	Left upper lobe	No	22	NAc	Yes	No
2	77	Male	1.65 (63.1)	Moderate	Right upper lobe	No	0.057	100	No	No
3	69	Male	2.55 (71.8)	Moderate	Right upper lobe	Yes	0	40	No	No
4	73	Male	2.04 (88.9)	Mild	Right middle lobe	No	20	30	Yes	No
5	79	Male	1.99 (78.5)	Moderate	Left upper lobe	Yes	0	40	Yes	No
6	79	Male	2.03 (69.8)	Moderate	Right upper lobe	No	30	45	No	No
7	54	Male	3.55 (90.3)	Mild	Right upper lobe	Yes	0	80	No	No
8	66	Female	2.01 (90.9)	Mild	Left upper lobe	Yes	0	18	No	No
9	72	Female	2.44 (67.1)	Moderate	Right lower lobe	No	12	30	No	No

^aICS inhaled corticosteroid

^bLABA long-acting beta-agonist

^cNA not available